Cystatin C (cys-C) is a small protein molecule (120 amino acid peptide chain, approximately
13kDa) produced by virtually all nucleated cells in the human body. It belongs to the family …

The search for molecules that may contribute to better identify patients at risk for
cardiovascular diseases (CVD) represents today an active field in clinical research. Few …

В обзоре рассмотрены возможности применения эндогенного индикатора
функционального состояния почек цистатина С (Цис С). Дана оценка результатам …

Background—Chronic kidney disease is a growing public health problem that carries
substantial risk for cardiovascular disease (CVD). Single studies have differentially …

Background Cystatin C (Cys‐C) is a marker of renal function that has shown prognostic
value for cardiovascular risk stratification across different patient populations. The …

Biomarkers in Heart Failure and Kidney Disease which the primary failing organ can be
either the heart or the kidney. Recently, Ronco et al discussed the different heart–kidney …

Background In cardiogenic shock (CS) renal dysfunction is an important parameter of
inadequate end-organ perfusion and an independent predictor of adverse outcome. Early …

BACKGROUND: Cystatin C has emerged as a new biomarker of renal function that has
been found to predict adverse cardiovascular outcomes, especially heart failure (HF) …

Background: This study examines whether the serum concentration of cystatin C (Cys C)
correlates with the severity of coronary artery disease (CAD) and whether it provides …

Cystatin C is a marker of renal dysfunction, and preliminary studies have suggested it might
have a role as a prognostic marker in patients with coronary artery disease. The aim of the …